ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years

June 9, 1978

Lung cancer screening trial reaches accrual goal of 50,000.

January 30, 2004

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

October 26, 2012

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

New Prostate Cancer Detection Group to Study Ultrasound

March 6, 1987

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001